Menu

Anagrelide Medication Guide: Dosage, Efficacy and Side Effects Explained

Author: MedicalHalo
Release time: 2026-03-13 05:38:15

  Anagrelide is an oral platelet production inhibiting medication.Its core mechanism works by inhibiting megakaryocyte differentiation,thereby reducing platelet production.This medication is primarily used for treating essential thrombocythemia(ET)and other related blood system disorders.

  1.Primary Indications

  This product is mainly suitable for patients with essential thrombocythemia,especially those who have intolerance to other treatment options or unsatisfactory treatment outcomes.The core clinical treatment goal is to maintain platelet counts within a safe range,effectively reducing the risk of thrombosis and bleeding events.

  2.Dosage Recommendations

  The initial dosing recommendation is 0.5 milligrams daily,taken as a single dose.Subsequent adjustments can be made progressively based on patient platelet test results and body tolerance status.The daily dosage upper limit is typically controlled within 5 milligrams.All dosage changes must be completed under professional physician guidance.

  3.Proper Administration Methods

  This product is administered via oral route,and can be taken with or without food.It is recommended to take medication at fixed times daily to maintain blood drug concentration stability.Tablets must be swallowed whole,splitting or crushing is prohibited.Please consume adequate water when taking medication.

  4.Treatment Efficacy Tracking

  Platelet counts need regular monitoring during medication period.Initially,weekly testing is recommended.After condition stabilizes,testing intervals can be appropriately extended.Physicians will adjust medication plans based on test results.When platelet counts return to normal range,maintenance treatment phase should begin.

  5.Potential Adverse Reactions

  Common adverse reactions include headache,rapid heartbeat,nausea,diarrhea and other symptoms.Some patients may experience arrhythmia or fluid retention phenomena.Regular electrocardiogram and weight change checks are needed during treatment period.Most adverse reactions are mild to moderate in severity.

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。

Agrylin
描述
Anagrelide InstructionsCommon name: AnagrelideTrade name: AnagrelideFull names: anagrelide, anagrelide hydrochloride, chloroquine imidazolone, Agrylin [ 详情 ]
微信在线客服